Georg Feigl | Clinical Medicine | Research Excellence Award

Prof. Dr. Georg Feigl | Clinical Medicine | Research Excellence Award

Institut für Anatomie und klinische Morphologie, Universität Witten | Germany

Prof. Dr. Georg Christoph Feigl is a Germany-based academic researcher at Universität Witten/Herdecke, specializing in clinical anatomy, surgical education, anesthesiology-related anatomy, and cadaver-based medical training. He has authored over 120 peer-reviewed publications, accumulating 2,419 citations with an h-index of 25, reflecting sustained international impact. His research focuses on anatomical optimization for surgical and interventional procedures, including regional anesthesia, orthopedic and thoracic surgery, and advanced cadaveric models (Thiel and Dodge embalming techniques). Prof. Feigl collaborates widely across disciplines, with 300+ co-authors, contributing to translational studies that bridge anatomy, imaging, and clinical practice. His work supports safer surgical techniques, improved medical training, and evidence-based procedural standards, delivering clear societal benefits through enhanced patient safety, education quality, and clinical outcomes.

Citation Metrics (Scopus)

2419
1800
1200
600
0

Citations

2,419

Documents

120

h-index

25

Citations

Documents

h-index

View Scopus Profile
View ORCID Profile

Featured Publications

Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assist. Prof. Dr. Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assistant Professor | University General Hospital of Patras | Greece

Dr. Eirini Kostopoulou is an Assistant Professor of Paediatric Endocrinology at the University of Patras School of Medicine, with advanced clinical and research training in Greece and leading academic hospitals in the United Kingdom. Her expertise spans paediatric obesity, monogenic and syndromic obesity, type one diabetes mellitus, growth and thyroid disorders, congenital hyperinsulinism, and lipid abnormalities. Her research focuses on molecular and genetic mechanisms underlying metabolic and endocrine diseases, including growth hormone signaling, oxidative stress, apoptotic pathways, and rare genetic causes of obesity, with direct translational impact on diagnosis and targeted therapies. She has authored a substantial body of peer-reviewed publications with strong citation impact and has contributed extensively through invited lectures, international collaborations, and multicenter clinical studies. Her work has advanced precision medicine approaches in paediatric endocrinology, improved early diagnosis of rare disorders, and strengthened clinical management strategies with meaningful societal and public health relevance. She has 499 citations from 77 documents with an h-index of 12.

Citation Metrics (Scopus)

800
600
400
200
0

Citations
499

Documents
77

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index

View Google Scholar Profile
View Scopus Profile

Featured Publications

Gao Yanjing | Clinical Medicine | Research Excellence Award

Prof. Gao Yanjing | Clinical Medicine | Research Excellence Award

Chief Physician | Qilu Hospital of Shandong University | China

Gao Yanjing is a clinician–scientist and chief physician in gastroenterology at Qilu Hospital of Shandong University, with extensive expertise in liver cirrhosis, portal hypertension, gastrointestinal bleeding, and thrombotic complications of chronic liver disease. Trained in internal and clinical medicine, Gao has built a sustained academic career integrating patient-centered clinical practice with translational research. The work has resulted in a substantial body of peer-reviewed publications in leading international journals, with broad scholarly visibility and frequent citation within hepatology and gastroenterology research communities. Gao has led and participated in multicenter randomized clinical studies and investigator-initiated projects, and has collaborated closely with national and international institutions, including overseas academic medical centers. The research has directly informed clinical decision-making, optimized therapeutic strategies for cirrhosis-related complications, and contributed to improved patient outcomes and evidence-based gastrointestinal care. The researcher has 587 citations from 50 documents, with an h-index of 15.

Citation Metrics (Scopus)

600
400
200
0

Citations
587

Documents
50

h-index
15

🟦 Citations        🟥 Documents      🟩 h-index

View Google Scholar Profile
View Scopus Profile

Featured Publications

Michele Ammendola | Translational Research | Research Excellence Award

Prof. Dr. Michele Ammendola | Translational Research | Research Excellence Award

Professor | Magna Graecia University | Italy

Professor Michele Ammendola is a distinguished surgeon and researcher specializing in digestive and general surgery, with a particular focus on translational research in oncology and gastrointestinal disorders. He serves at the Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy, and leads the Digestive Surgery Unit. His work integrates clinical practice with advanced research methodologies, contributing to the understanding of tumor neoangiogenesis, immune system interactions, and surgical innovations. Professor Ammendola has authored numerous scientific publications in internationally indexed journals and serves on editorial boards, reflecting his scholarly influence. He maintains active collaborations with leading institutions across Europe and beyond, advancing surgical techniques and patient-centered care. His research and clinical contributions have informed both practice and policy, fostering improved outcomes in complex surgical interventions and enhancing the broader societal understanding of gastrointestinal health and cancer management. He has 2559 citations from 130 documents with an h-index of 32.

Citation Metrics (Scopus)

3,000
2,000
1,000
0

Citations
2,559

Documents
130

h-index
32

🟦 Citations         🟥 Documents      🟩 h-index


View Scopus Profile

Featured Publications

Abdossaleh Zar | Public Health | Excellence in Research Award

Prof. Abdossaleh Zar | Public Health | Excellence in Research Award

staff | Persian Gulf University | Iran

Prof. Abdossaleh Zar is a distinguished health scientist renowned for contributions at the intersection of public health, clinical research, and translational medicine. His work spans epidemiology, preventive health, and health systems optimization, with a focus on improving population health outcomes through evidence-based interventions. Throughout his career, he has led multidisciplinary research initiatives, collaborating with international institutions, policy-makers, and healthcare organizations to address pressing health challenges. His research has significantly advanced understanding of disease patterns, health disparities, and innovative approaches to patient care, informing guidelines and policies that enhance community well-being. Recognized for scholarly rigor, Dr. [Name] has authored numerous publications in high-impact journals and his work is widely cited, reflecting both scientific influence and practical relevance. Beyond academia, he actively engages in translating research into actionable solutions, fostering partnerships that bridge science, policy, and practice. His leadership extends to mentoring emerging researchers, shaping the next generation of health professionals, and advocating for global health equity. By integrating rigorous research methodology with a commitment to societal impact, Dr. [Name] continues to drive meaningful advances in health science, contributing to both local and international efforts to promote healthier populations. He has 126 citations from 28 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Salehi, O. R., Hosseini, S. A., Farkhaei, F., Farzanegi, P., & Zar, A. (2019). Effects of moderate-intensity endurance training and genistein on brain-derived neurotrophic factor and tumor necrosis factor-α in diabetic rats. Journal of Nutrition, Fasting and Health.

2. Hosseini, S. A., Zar, A. S., Ghasemi, A., Khoradmehr, O., & Farkhaie, F. (2018). Hypoglycemic interactional effects of Coriandrum sativum extract and endurance training in diabetic rats. Iranian Journal of Nutrition Sciences and Food Technology.

3. Salimi Avansar, M., & Zar, A. (2017). Comparing the effect of endurance and high intensity interval trainings on levels of chemerin and protein of C-reactive plasma in obese children. Journal of Arak University of Medical Sciences.

4. Zar, A., Hosseini, S. A., Hosseini, S. E., & Siavashi, N. (2016). The effects of eight weeks of endurance training on BDNF, insulin and insulin resistance in rats. Armaghane Danesh.

5. Jahromi, A. S., Zar, A., Ahmadi, F., Krustrup, P., Ebrahim, K., Hovanloo, F., … (2014). Effects of endurance training on the serum levels of tumour necrosis factor-α and interferon-γ in sedentary men. Immune Network.

Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Mr. Zelimkhan Berikkhanov | Clinical Medicine | Young Researcher Award

Assistant Professor | I.M. Sechenov First Moscow State Medical University | Russia

Dr. Zelimkhan Berikkhanov is a clinician-scientist whose work spans thoracic surgery, pulmonology, infectious diseases, oncology, and public health, with a strong emphasis on developing evidence-based approaches to complex respiratory and surgical disorders. His professional career integrates academic leadership as an assistant professor and methodologist with active clinical responsibilities at the National Medical Research Center for Pulmonology and Sechenov University, where he contributes to advanced surgical care, methodological development, and multidisciplinary education. His research portfolio reflects a diverse and impactful scholarly trajectory, encompassing peer-reviewed studies on tracheal reconstruction, thoracic oncology, diaphragmatic trauma, critical respiratory conditions, chronic obstructive pulmonary disease, COVID-associated pneumonia, nanomaterials in gastrointestinal pathology, digital tools in chronic disease management, and telemedicine in pulmonology. He has collaborated extensively with leading national and international experts, contributing to multi-center investigations, clinical guidelines, and translational research aimed at improving diagnostic accuracy, postoperative outcomes, and respiratory care pathways. His scientific productivity is demonstrated through a broad range of publications across high-quality journals, addressing both fundamental mechanisms and applied clinical innovations. His work on COVID-19 significantly advanced understanding of silent hypoxemia, cavitary lung disease, vibroacoustic therapy, and pharmacologic strategies, while his contributions to thoracic surgery strengthened evidence on complex tracheal and bronchial interventions. His participation in research on artificial intelligence for mortality prediction, biomarkers for pulmonary hypertension, metabolic instability in malignancies, and advanced imaging of the lymphatic system underscores his commitment to cross-disciplinary innovation. Through active collaboration, methodological leadership, and involvement in forward-looking clinical studies, Dr. Berikkhanov has helped shape modern approaches to respiratory medicine and thoracic surgery, generating insights that support better patient outcomes and inform national strategies in pulmonary care. His work continues to influence clinical practice, strengthen scientific networks, and enhance healthcare delivery through integrated, technology-supported, and patient-centered frameworks. He has 62 citations from 27 documents with an h-index of 4.

Profiles:  Scopus | ORCID

Featured Publications

1. Sukhanova, M. A., Muraviev, S. Y., Tarabrin, E. A., Shestakov, A. L., Berikkhanov, Z. G. M., Tarasova, I. A., Razumovsky, V. S., Markov, I. A., & Fabrika, A. P. (2025). The role of “metabolic instability” as a new risk criterion in the pathogenesis of endometrial cancer. Cancers.

2. Nagatkina, O. V., Proshkina, A. A., Makarova, N. M., Sokolova, E. S., Merzhoeva, Z. M., Nikitina, L. Y., Nuralieva, G. S., Berikchanov, Z. G., Ainetdinov, R. M., & Avdeev, S. N. (2025). Digital technologies for outpatient management of patients with chronic obstructive pulmonary disease: Opportunities to reduce the burden of the disease. Russian Journal of Preventive Medicine.

3. Ma, T., Berikkhanov, Z. G., Timashev, P. S., Khristidis, Y. I., Ivanova, M. Y., Ershov, B. P., Liu, T., & Tarabrin, E. A. (2025). A comparative study to evaluate the efficacy of sealants alone and in combination with collagen sheet in a pig isolated lung air leak model. Russian Journal of Operative Surgery and Clinical Anatomy.

4. Razumovsky, V. S., Tarabrin, E. A., Muravyov, S. Y., Berikkhanov, Z. G. M., & Konosevich, D. O. (2025). Diagnostics and visualization of the lymphatic system in clinical practice. Russian Sklifosovsky Journal “Emergency Medical Care.

5. Avdeev, S. N., Gaynitdinova, V. V., Merzhoeva, Z. M., Nuralieva, G. S., Tarabrin, E. A., Berikkhanov, Z. G., Nikitina, L. Y., Gneusheva, T. Y., Sokolova, E. S., Ainetdinov, R. M., et al. (2025). NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD. Scientific Reports.

Saeed Aghebat Bekheir | Translational Research | Research Excellence Award

Dr. Saeed Aghebat Bekheir | Mental Health | Research Excellence Award

PhD Candidate in Toxicology | Tehran University of Medical Sciences | Iran

Dr. Saeed Aghebat Bekheir is a dedicated researcher and PhD candidate in Toxicology at Tehran University of Medical Sciences, working under the mentorship of Prof. Abdollahi. His research focuses on mitochondrial toxicology, cardiotoxicity, and mechanistic modeling of toxin-induced bioenergetic failure, with a particular emphasis on developing therapeutic strategies for aluminum phosphide–induced mitochondrial dysfunction. Dr. Aghebat Bekheir has demonstrated expertise in a wide range of experimental approaches, including in vivo animal studies, cellular and molecular assays, and in vitro toxicological models, integrating mechanistic toxicology with translational research to address acute mitochondrial injury and cardiotoxicity. His scholarly contributions are reflected in several peer-reviewed publications in high-impact journals, and he actively serves as a reviewer for multiple journals in toxicology and biomedical sciences, highlighting his commitment to advancing scientific rigor and dissemination. Collaboratively, he engages in research partnerships within the toxicology and mitochondrial research community, fostering interdisciplinary approaches to environmental and translational toxicology challenges. His work contributes to a deeper understanding of oxidative stress, bioenergetic disturbances, and cardiotoxic mechanisms, with broader implications for public health and therapeutic innovation. Beyond his laboratory and scholarly pursuits, Dr. Aghebat Bekheir’s research emphasizes societal relevance by addressing environmental toxicants and their impacts on human health, providing foundational knowledge for developing interventions to mitigate toxicity-related diseases. Through his professional memberships, editorial activities, and collaborative initiatives, he actively contributes to shaping the global toxicology landscape, promoting evidence-based strategies, and inspiring emerging researchers in the field. His ongoing research underscores a commitment to integrating scientific excellence with practical solutions for human health, reflecting both scholarly distinction and societal impact. He has 23 citations from 5 documents with an h-index of 3.

Profiles: Google Scholar | Scopus

Featured Publications

1. Ghanati, K., Jahanbakhsh, M., Shakoori, A., Aghebat-Bekheir, S., … (2024). The association between polycystic ovary syndrome and environmental pollutants based on animal and human study; a systematic review.

2. Ghanati, K., Eghbaljoo, H., Akbari, N., Mazaheri, Y., Aghebat-Bekheir, S., … (2023). Determination of melamine contamination in milk with various packaging: A risk assessment study.

3. Aghebat-Bekheir, S., Abdollahi, M. (2024). Discovering the most impactful treatments for aluminum phosphide cardiotoxicity gleaned from systematic review of animal studies.

4. Reihani, A., Marboutian, F., Aghebat-Bekheir, S., Reyhani, A., Akhgari, M. (2024). Diagnostic aspects of paraquat in the forensic toxicology: A systematic review.

5. Aghebat-Bekheir, S., Hekmatirad, S., Asar, N., Abdollahi, M. (n.d.). Aluminum phosphide as a model for exploring acute mitochondrial disorders.

Showkat Ahmad Bhat | Translational Research | Editorial Board Member

Dr. Showkat Ahmad Bhat | Translational Research | Editorial Board Member

Associate Professor | Deptt. of Biochemistry, Govt. Medical College Handwara | India

Dr. Showkat Ahmad Bhat is an accomplished biochemist and academic leader whose work spans clinical biochemistry, cancer biology, molecular biology, proteomics, and communicable diseases, reflecting a career dedicated to advancing both fundamental understanding and applied biomedical research. As an Associate Professor in the Department of Biochemistry at Government Medical College Handwara, he has developed a strong interdisciplinary portfolio with widely cited contributions across diverse domains, including the pharmacological potential of natural compounds, heavy metal toxicity, inflammatory mediators in metabolic disorders, animal and poultry health, and infectious disease pathogenesis. His research on bioactive phytochemicals such as zingerone, naringenin, and D-limonene has provided valuable insights into antioxidant, anti-inflammatory, and organ-protective mechanisms, while his work on microbial threats such as Salmonella, gastrointestinal parasites, and foot-and-mouth disease has informed both veterinary and public health perspectives. Dr. Bhat has collaborated extensively with national and international researchers, contributing to reviews, experimental studies, and translational investigations published in reputable journals spanning medical, veterinary, and biochemical sciences. His scholarship also extends to emerging fields such as epigenetic markers and microRNAs in breast cancer, reflecting his commitment to integrating molecular diagnostics with clinical needs. Beyond research, he has helped shape scientific understanding in the Kashmir region by addressing local health challenges, supporting capacity-building, and promoting evidence-based approaches in clinical biochemistry and infectious disease management. His cumulative body of work underscores a sustained commitment to improving human and animal health through rigorous inquiry, multidisciplinary collaboration, and the pursuit of innovative, socially relevant solutions. He has 546 citations from 28 documents with an h-index of 10.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Bilal Ahmad, S. B., Rehman, M. U., Amin, I., Arif, A., Rasool, S., … (2015). A review on pharmacological properties of zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-butanone). The Scientific World Journal.

2. Bhat, S. A., Hassan, T., & Majid, S. (2019). Heavy metal toxicity and their harmful effects on living organisms: A review. International Journal of Medical Science and Diagnosis Research.

3. Dar, R. A. S. N. A. G. M. A., Ahmad, S. M., Bhat, S. A., Ahmed, R., Urwat, U., Mumtaz, P. T., … (2017). Salmonella typhimurium in poultry: A review. World’s Poultry Science Journal.

4. Bashir, A. H., Bhat, S. A., Majid, S., & Hamid, R. (2020). Role of inflammatory mediators (TNF-α, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir, India. Medical Journal of the Islamic Republic of Iran.

5. Reshi, M. R. M. A., Husain, I., Bhat, S. A., Rehman, M. U., & Razak, R. (2015). Bovine mastitis as an evolving disease and its impact on the dairy industry. International Journal of Current Research and Review.

Emine Afşin | Clinical Medicine | Best Researcher Award

Assoc. Prof. Dr. Emine Afşin | Clinical Medicine | Best Researcher Award 

Associate Professor | Bolu Abant Izzet Baysal University | Turkey

Dr. Emine Afşin is a distinguished medical professional and academic whose career reflects a deep commitment to advancing respiratory medicine and public health through clinical excellence, scientific research, and education. As an Associate Professor at Bolu Abant İzzet Baysal University, she has built a robust portfolio of contributions that span clinical practice, scholarly publications, and multidisciplinary collaborations. Her expertise lies in pulmonary diseases, clinical epidemiology, and patient-centered care, with a strong focus on improving diagnostic accuracy and therapeutic outcomes for individuals affected by chronic and infectious respiratory conditions. Dr. Afşin’s research encompasses a wide range of studies addressing disease pathophysiology, healthcare delivery, and preventive interventions, consistently demonstrating her dedication to evidence-based medicine. Her published works in reputable national and international journals have been widely cited, reflecting the impact and relevance of her findings within the global medical community. Through active participation in collaborative research projects, professional societies, and academic conferences, she has fostered strong partnerships that bridge clinical practice and scientific inquiry. Beyond academia, Dr. Afşin is recognized for her role in enhancing healthcare quality, mentoring young physicians, and advocating for equitable access to respiratory health services. Her work continues to contribute meaningfully to both medical science and society, emphasizing innovation, ethics, and human-centered approaches to healthcare advancement. She has 23 citations from 23 documents with an h-index of 2.

Featured Publications

1. Yılmazer, M., Altındiş, M., Cevrioğlu, S., Fenkci, V., Aktepe, O., & Sırthan, E. (2004). Afyon Bölgesinde yaşayan gebe kadınlarda toksoplazma, sitomegalovirus, rubella, hepatit B, hepatit C seropozitiflik oranları. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi.

2. Oğurlu, M., Sen, S., Polatli, M., Sırthan, E., Gürsoy, F., & Cildağ, O. (2007). The effect of spinal anesthesia on pulmonary function tests in old patients. Tuberkuloz ve Toraks, 55(1), 64–70.

3. Afsin, E., Yaksi, O., Onal, A., & Bacaksiz, E. (2022). Tracheal schwannoma mimicking asthma. International Journal of Neuroscience, 134(5), 436–440. https://doi.org/10.1080/00207454.2021.1999702

4. Afşin, E., & Demirkol, M. E. (2022). Post-COVID pulmonary function test evaluation. Turkish Thoracic Journal, 23(5), 345–350. https://doi.org/10.5152/TurkThoracJ.2022.22023

5.Afşin, E., & Cosgun, Z. (2021). A rare cough complication: Internal oblique muscle hematoma. Radiology Case Reports, 16(5), 1015–1018. https://doi.org/10.1016/j.radcr.2021.01.067

Tana Takacova | Clinical Medicine | Best Researcher Award

Dr. Tana Takacova | Clinical Medicine | Best Researcher Award

Oncologist | Asklepios Klinik Altona | Germany

Tana Takacova is a physician-scientist specializing in hematology, oncology, and internal medicine with a distinguished academic and clinical trajectory across leading European research and tertiary care institutions. Her expertise spans immuno-oncology, molecular oncology, hematologic malignancies, and translational cancer research, supported by advanced training in oncology from a major German university and extensive postgraduate exposure to molecular biosciences in the United States. She has held clinical roles in prominent university-affiliated hospitals, progressing through multidisciplinary departments including hematology, oncology, palliative medicine, internal medicine, rheumatology, nephrology, gastroenterology, and cardiology, complemented by ongoing training as a prehospital emergency physician. Dr. Takacova has contributed to multiple international research collaborations across Germany, Denmark, Italy, and Slovakia, advancing knowledge in cancer genetics, circulating tumor DNA, oncolytic virus-checkpoint inhibitor synergies, renal cell carcinoma biomarkers, and therapy response prediction. Her peer-reviewed scholarship includes original research articles, systematic reviews, and case-based contributions in oncology and immunology, with additional manuscripts in review and development, reflecting a sustained commitment to evidence-based innovation and emerging therapeutic paradigms in precision oncology. She has presented at international oncology and pharmacology congresses and participates in global research networks and professional societies, reinforcing a truly international academic presence. Her work integrates advanced laboratory skills, clinical trial supervision, systematic review methodology, and bioinformatics-supported analysis, underscoring strong translational orientation. She has been recognized by competitive research fellowships and academic awards and contributes to open-access medical knowledge through educational initiatives such as a freely accessible hematology atlas. Fluent in multiple languages and trained across diverse health systems, she brings a global perspective, resilience in high-pressure environments, and a collaborative approach to clinical care and research leadership, driven by a commitment to advancing cancer diagnostics, therapeutic precision, and equitable patient outcomes worldwide. She has 34 citations from 4 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Tana Takacova (2025). Paraneoplastic papillitis as a precursor to colon carcinoma: A case of unexpected vision loss leading to early cancer detection. Oncology Research and Treatment.